Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Stem Cells Researches and Therapies Towards Endocrine Diseases Treatment; Strategies, Challenges, and Opportunities Publisher



Sarvari M1 ; Alavimoghadam S2 ; Aghayan HR2 ; Tayanloobeik A2 ; Payab M1 ; Tootee A3 ; Sajjadijazi SM2, 4 ; Larijani B4 ; Arjmand B1, 2
Authors

Source: Journal of Diabetes and Metabolic Disorders Published:2021


Abstract

Due to the limitations of organ transplantation and the urgent need for treatment of chronic diseases, the benefit of stem cells for treatment has been studied and evaluated as an effective approach worldwide. One of the leading countries in this field is Iran. In this respect, several research and treatment institutes, including endocrinology and metabolism research institute are active in the use of stem cells in Iran. Herein, the aim is to review strategies, challenges, and opportunities for stem cell research and treatment in endocrinology and metabolism research institute. © 2021, Springer Nature Switzerland AG.
Related Docs
View other Related Docs
1. An Overview of Stem Cell and Regenerative Medicine Researches in Iran, Iranian Journal of Diabetes and Metabolism (2021)
2. How to Establish Infrastructures to Achieve More Efficient Regenerative Medicine?, Cell and Tissue Banking (2023)
3. The Fingerprints of Biomedical Science in Internal Medicine, Advances in Experimental Medicine and Biology (2022)
Experts (# of related papers)
View all Related Experts
Bagher Larijani (20)
Babak Arjmand (17)
Other Related Docs
4. The Outcome of Stem Cell-Based Therapies on the Immune Responses in Rheumatoid Arthritis, Advances in Experimental Medicine and Biology (2021)
5. Prospect of Stem Cell Therapy and Regenerative Medicine in Osteoporosis, Frontiers in Endocrinology (2020)
6. Assessment of Immune-Alternations and Their Correlations With Therapeutic Outcomes of Transplantation of Autologous Mesenchymal and Allogenic Fetal Stem Cells in Patients With Type 1 Diabetes: A Study Protocol, Journal of Diabetes and Metabolic Disorders (2021)
7. Stem Cell-Based Models and Therapies: A Key Approach Into Schizophrenia Treatment, Cell and Tissue Banking (2021)
8. Endocrinology and Metabolism Institute Over Time: A Quarter of a Century of Experience, Iranian Journal of Diabetes and Metabolism (2021)
9. Metabolomics Analysis of Mesenchymal Stem Cells, International Journal of Molecular and Cellular Medicine (2019)
10. Regenerative Medicine Perspectives in Polycystic Ovary Syndrome, Advances in Experimental Medicine and Biology (2021)
11. Application of Biocompatible Scaffolds in Stem-Cell-Based Dental Tissue Engineering, Advances in Experimental Medicine and Biology (2023)
12. Clinical Outcomes of Fetal Stem Cell Transplantation in Type 1 Diabetes Are Related to Alternations to Different Lymphocyte Populations, Medical Journal of the Islamic Republic of Iran (2022)
13. Auxiliary Role of Mesenchymal Stem Cells As Regenerative Medicine Soldiers to Attenuate Inflammatory Processes of Severe Acute Respiratory Infections Caused by Covid-19, Cell and Tissue Banking (2020)
14. Opportunities and Challenges in Stem Cell Aging, Advances in Experimental Medicine and Biology (2021)
15. Transplantation of Fetal Stem Cells: A New Horizon for Treatment of Degenerative Diseases, Iranian Journal of Public Health (2015)
16. Endocrinology and Metabolism Research Institute From Inception to Maturity: An Overview of 25-Year Activity, Journal of Diabetes and Metabolic Disorders (2020)
17. Achievements and Advances in Diabetes Research Over a Quarter of a Century: A Review of the Available Evidence, Iranian Journal of Diabetes and Metabolism (2021)
18. Gmp-Compliant Mesenchymal Stem Cell-Derived Exosomes for Cell-Free Therapy in Cancer, Methods in Molecular Biology (2024)
19. Therapeutic Abortion and Ectopic Pregnancy: Alternative Sources for Fetal Stem Cell Research and Therapy in Iran As an Islamic Country, Cell and Tissue Banking (2019)
20. Advancement of Organoid Technology in Regenerative Medicine, Regenerative Engineering and Translational Medicine (2023)